WEALTHGATE Biotech Fund R
| MVD-Fonds Rating | EDA |
|---|---|
| Kein Rating vorhanden | 73 |
ISIN: DE000A3ETA12 | WKN: A3ETA1
KAG: HANSAINVEST
NAV: 134,78 USD am 13.02.2026
Monatsperformance WEALTHGATE Biotech Fund R
| 2026 | 2025 | 2024 | |||
| Januar | +3,95% | +1,16% | - | ||
| Februar | -3,19% | -5,59% | - | ||
| März | - | -3,46% | -2,63% | ||
| April | - | -1,98% | -6,07% | ||
| Mai | - | -1,09% | -1,27% | ||
| Juni | - | +3,70% | +4,61% | ||
| Juli | - | +0,47% | +5,45% | ||
| August | - | +8,82% | +2,31% | ||
| September | - | +11,53% | -2,55% | ||
| Oktober | - | +15,49% | -0,73% | ||
| November | - | +6,60% | +1,13% | ||
| Dezember | - | -2,03% | -4,64% | ||
| Gesamt | +0,63% | +36,33% | -4,93% |
Performanceverteilung in Monats-Bausteinen
| 2/26 | ||||||||||
| 12/25 | ||||||||||
| 5/25 | ||||||||||
| 4/25 | 1/26 | |||||||||
| 3/25 | 7/25 | |||||||||
| 12/24 | 6/25 | |||||||||
| 10/24 | 1/25 | |||||||||
| 9/24 | 11/24 | 11/25 | ||||||||
| 2/25 | 5/24 | 8/24 | 8/25 | |||||||
| 4/24 | 3/24 | 6/24 | 7/24 | 9/25 | 10/25 | |||||
| -20% | -15% | -10% | -5% | 0% | 0% | 5% | 10% | 15% | 20% |




Vortrag am FONDS professionell KONGRESS
Portfolio
Watchlist
Kursalarm